MedPath

nderstanding the utilisation of an insulin-to-protein ratio in people with type 1 diabetes who follow a carbohydrate-restricted diet.

Not Applicable
Completed
Conditions
Type 1 Diabetes Mellitus
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12619000208101
Lead Sponsor
Capital and Coast District Health Board
Brief Summary

A total of 34 participants were recruited of which 16 were randomly assigned to the intervention group and 18 to the control group. There was one withdrawal from the intervention group and two withdrawals from the control group. The intervention group did not have any significant improvements in haemoglobin A1c, glycaemic variability, time spent in normal glycaemic range or hyperglycaemia compared with the control group. However, there was no significant increase in time spent in hypoglycaemia for either group. There were no significant changes in weight or BP for either group. Qualitative data indicated that some participants found the insulin-to-protein ratio helped them feel more in control of their diabetes while others found that it increased their distress.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
34
Inclusion Criteria

People with type 1 diabetes mellitus who follow a basal-bolus insulin regimen and attend diabetes clinics at Capital and Coast Health.

Exclusion Criteria

Pregnant or planning pregnancy
Breast-feeding
Unstable diabetes control (HbA1c>85 mmol/mol)
Kidney disease (EGFR<30 or on dialysis)
Hypoglycaemia unawareness, defined as a recurrent failure to detect a significant fall in blood glucose below normal levels
People who undertake more than 15 hours of moderate to intense exercise per week
History of gastroparesis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1c at three months adjusted for baseline, assessed by blood test at Endocrine, Diabetes & Research Centre, CCDHB[Three months after randomisation]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath